Interview with Albert Saporta, President and CEO, Stallergenes
Can you highlight some of the more recent milestones for Stallergenes? Stallergenes has been successful over recent years for several reasons, the first of which is the growth of the…
NOVASEP: Services and technologies for the life science and chemical industries
Novasep is a leading provider of services in the field of molecule production and purification for the life science and chemical industries, based on an unrivalled pool of specialized technologies.
Our unique business model addresses our customers’ manufacturing strategies, and is based on 2 sets of offerings for 7 markets.
Pharmaceuticals
Biopharmaceuticals
Fine chemicals
Agrochemicals
Food ingredients
Functional ingredients
Fermentation & chemical commodities
Process development and contract manufacturing of:
Process engineering, supply of equipment and related services for:
With 1,100 employees, Novasep is established in Europe, Asia and North America and is constantly expanding its presence to better serve its customers.
We aim to be a highly respected, top tier service provider in all our market segments through the passion of our people and the excellence of our processes.
Contact
39, rue Saint-Jean de Dieu
69007, Lyon
FRANCE
Phone : +33 437 282 030
Can you highlight some of the more recent milestones for Stallergenes? Stallergenes has been successful over recent years for several reasons, the first of which is the growth of the…
As Quintiles is present in all major pharmaceutical markets worldwide, what’s the relevance of the French affiliate and what role it plays inside such a globalized organization? France is important…
When we met your Italian colleague, he noted that they had tripled their turnover in a five year period. You haven’t done badly yourself in the relatively short period of…
Biogaran was an initiative from Servier in the mid 1990s before there was even a generic pharmaceutical market in France. Could you speak of your history and of the origins…
Janssen-Cilag is involved in not only selling its products in France but research and production as well. As France is a leading subsidiary, can you speak to the importance of…
Endotis was incorporated in 2003 on the basis of a technology transfer from on a French public research institution. Can you elaborate on the origins? The group was founded from…
This interview was conducted with Jacques de Chilly and Theirry de Lumley of Aderly hereafter referred to as J.C. and T.L. respectively. Aderly was founded in 1974 in order to…
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
CIP and GERS have very unique relationships with the pharmaceutical industry. Could you elaborate on the role of these two bodies? Club Inter-pharmaceutique (CIP) is a professional association created in…
As a majority of our readers are American that may be used to a different model of clusters can you explain the unique characteristics of the pôles de compétitivité? The…
Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How is Eisai in France…
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health…
See our Cookie Privacy Policy Here
